Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L32 pseudogene 29 (RPL32P29)
- Target
- RPL32P29
- Molecular classification
- Other (Processed pseudogene)
01
Overview
Ribosomal protein L32 pseudogene 29 (RPL32P29) is a human processed pseudogene—an inactive genomic DNA sequence that is similar to the functional ribosomal protein L32 gene but does not encode a functional protein. Pseudogenes such as RPL32P29 arise through retrotransposition or genomic duplication of the parent gene but typically lack regulatory elements, introns, or may have mutations that prevent protein expression. RPL32P29 is listed as a non-functional pseudogene in genomic and nomenclature databases and is not recognized as a therapeutic target, receptor, enzyme, or biomarker. There is no evidence of its involvement in disease biology, drug interactions, or clinical relevance. The canonical functional gene, RPL32, encodes a protein that is a component of the large 60S ribosomal subunit, but this pseudogene does not contribute to that activity.
- Other names
- RPL32_8_1362RPL32P29
02
Biological functions
Other (processed pseudogenes are generally transcriptionally inactive and do not encode proteins; functional roles are uncommon, but occasional pseudogenes may have regulatory RNA roles depending on context)
03
Disease associations
Other (no direct evidence for disease involvement for RPL32P29; the parental gene RPL32, not RPL32P29, is implicated in ribosome biogenesis and translation)
Beyond the preview
Go deeper on Ribosomal protein L32 pseudogene 29 (RPL32P29).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L32 pseudogene 29 (RPL32P29).